PGEN peer analysis
Precigen (PGEN) against its competitors: price, today's move, 1-year return and market value side by side.
PGEN and its peers
| Company | Price | Today | 1-year return | Market cap |
|---|---|---|---|---|
| ABEO Abeona Therapeutics | $4.35 | -4.61% | -14.37% | $248.75M |
| CRSP CRISPR Therapeutics | $50.22 | -2.33% | -17.81% | $4.97B |
| DTIL Precision BioSciences | $7.06 | -5.11% | -18.00% | $194.87M |
| EDIT Editas Medicine | $2.65 | -0.94% | -12.13% | $410.06M |
| GNPX Genprex | $2.24 | 9.80% | -98.38% | $1.84M |
| MGX Metagenomi Therapeutics | $0.78 | -6.01% | -68.02% | – |
| NTLA Intellia | $11.80 | -5.37% | -3.79% | $1.75B |
| RCKT Rocket Pharmaceuticals | $2.44 | -3.94% | -34.05% | $267.85M |
| RGNX REGENXBIO | $7.20 | -2.83% | -43.84% | $475.29M |
| SNTI Senti Biosciences | $0.17 | -23.92% | -92.21% | – |
| PGEN Precigen | $5.30 | -23.63% | 30.86% | $2.48B |
- PGEN's peers: ABEO (Abeona Therapeutics), CRSP (CRISPR Therapeutics), DTIL (Precision BioSciences), EDIT (Editas Medicine), GNPX (Genprex), MGX (Metagenomi Therapeutics), NTLA (Intellia), RCKT (Rocket Pharmaceuticals).
Updated 2026-11-02 17:55 UTC